| Financial Year |
March 31 2023 |
| Monetary Funds |
58,587,864.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
67,175,079.02 |
| Advances to Suppliers |
6,002,046.72 |
| Other Receivables |
693,778.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,959,411.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,356,531.60 |
| Total Current Assets |
180,283,282.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
432,569,134.58 |
| Under-construction Projects |
4,817,012.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,333,958.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,059,849.32 |
| Other Non-Current Assets |
231,738.47 |
| Sub-Total of Non-Current Assets |
476,164,512.63 |
| Total Assets |
656,447,795.10 |
| Short-Term Loans |
6,680,498.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,463,432.55 |
| Accounts Payable |
39,737,143.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,358,981.57 |
| Taxes Payable |
5,378,664.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
407,934.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
706,767.60 |
| Other Current Liabilities |
10,758.45 |
| Sub-Total of Current Liabilities |
76,267,722.92 |
| Long-term Loans |
26,603,936.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,443,851.35 |
| Total Liabilities |
106,711,574.27 |
| Paid-In Capital(Or Share Stock) |
231,154,000.00 |
| Capital Surplus |
174,663,789.98 |
| Surplus Reserve |
20,121,627.58 |
| LESS:Treasury Stock |
1,135,250.00 |
| Undistributed Profits |
124,939,950.77 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
549,736,220.83 |
| Owner's Equity（Stockholder's Equity） |
549,736,220.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
656,447,795.10 |
